Ingelsby, Director of Health at Johns Hopkins fields questions about the unpreparedness of our health system. “How is it that we are in a shortage situation again?” He says that it is the nature of a continued problem and that a national dashboard to provide visibility to the supply chain for PPE and tests would help greatly.
Cancer, a word that strikes a chord of fear in many, is a fighting word. At $47.7bn, cancer is one of the largest, fastest growing markets in the pharmaceutical industry, and while it is a match we have yet to win, researchers and scientists have on their boxing gloves and are staying in the fight.
Advanced Life Sciences (OTC BB: ADLS) took two steps this week toward advancing its lead drug candidate, Restanza.
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.